Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rivastigmine: a review.

A Sim1

  • 1Udston Hospital, Hamilton, Lanarkshire.

Hospital Medicine (London, England : 1998)
|February 3, 2000
PubMed
Summary

Acetylcholinesterase inhibitors offer palliative treatment for Alzheimer's type dementia. Rivastigmine, a second-generation inhibitor, shows significant clinical relevance and therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authors' Response to Correspondence Re Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester Community.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Oral Cavity Cancers: Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester Community.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

An evaluation of a common elements treatment approach for youth in Somali refugee camps.

Global mental health (Cambridge, England)·2018
Same author

Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical steps.

International braz j urol : official journal of the Brazilian Society of Urology·2016
Same author

[Treatment of invasive bladder cancer: robot-assisted radical cystectomy and intracorporeal urinary diversion].

Der Urologe. Ausg. A·2014
Same author

[Laparoscopic partial nephrectomy for renal tumors. Time for a new standard?].

Der Urologe. Ausg. A·2014

Area of Science:

  • Neuroscience
  • Pharmacology
  • Geriatrics

Background:

  • Alzheimer's type dementia is a progressive neurodegenerative disorder.
  • Acetylcholinesterase inhibitors represent the primary pharmacotherapy for managing dementia symptoms.
  • Palliative treatment aims to alleviate symptoms and improve quality of life for patients.

Purpose of the Study:

  • To review rivastigmine, a second-generation carbamate cholinesterase inhibitor.
  • To discuss the clinical relevance of rivastigmine's pharmacology.
  • To explore potential therapeutic applications of rivastigmine.

Main Methods:

  • Literature review of rivastigmine's pharmacological properties.
  • Analysis of clinical data and therapeutic outcomes.
  • Discussion of future research directions.

Main Results:

  • Rivastigmine is a carbamate cholinesterase inhibitor with demonstrated clinical utility.
  • Its unique pharmacological profile offers immediate therapeutic benefits.
  • The drug presents promising avenues for future Alzheimer's treatment strategies.

Conclusions:

  • Rivastigmine is a valuable option for the palliative care of Alzheimer's type dementia.
  • Understanding its pharmacology is crucial for optimizing patient outcomes.
  • Further research may unlock expanded therapeutic uses for rivastigmine.

Related Experiment Videos